Leslie Andersen

Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone

Eric D. Bateman, Paul M. O’Byrne, Jan Lötvall et al. · Thorax · 2013 · 87 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β₂agonist vilanterol administered once daily for 52 weeks in patients ≥12 years old with asthma: a randomised trial

Paul M. O’Byrne, Eugene R. Bleecker, Jan Lötvall et al. · Thorax · 2013 · 75 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Functional Chest Pain

Ranjit S. Mudipalli, J.M. Remes-Troche, Leslie Andersen et al. · Journal of Clinical Gastroenterology · 2007 · 49 citations

Medicine, Clinical Sciences, Internal Medicine +14

Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?

Steven M. Koenig, John Murray, James Wolfe et al. · Respiratory Medicine · 2008 · 26 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +8

Once-daily fluticasone furoate/vilanterol <i>versus</i> twice-daily fluticasone propionate/salmeterol in patients with asthma well controlled on ICS/LABA

David I. Bernstein, Leslie Andersen, Richard Forth et al. · Journal of Asthma · 2017 · 16 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14